Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001641172-25-001849
Filing Date
2025-03-31
Accepted
2025-03-31 17:15:24
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-03-31

Document Format Files

Seq Description Document Type Size
1 formnt10-k.htm NT 10-K 38004
  Complete submission text file 0001641172-25-001849.txt   39115
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-38022 | Film No.: 25794958
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)